Blog

Bringing a new therapeutic to market is a challenging and costly endeavor. Strong intellectual property protections, which enable manufacturers to recoup their successful investments into new treatments, are absolutely essential to encouraging innovation. However, activists and government regulators who seek to weaken IP rights often fail to recognize this fundamental reality. One example of this

C4IP Co-Chair and former USPTO Director Andrei Iancu, along with Mark Cohen, the former director of UC Berkeley’s Asia IP Project, recently published an opinion piece in the International Business Times focusing on China’s secretive policy of issuing anti-suit injunctions, which puts innovative American companies at a major disadvantage when fighting patent theft from Chinese

This month, C4IP is recognizing William Coolidge, who transformed medicine with his invention of the modern X-ray. Coolidge was born in 1873 in Hudson, Massachusetts, and studied electrical engineering at Massachusetts Institute of Technology (MIT) and the University of Leipzig before joining the General Electric Research Laboratory. He earned more than 80 patents during his

C4IP was busy over the past month! Here’s a roundup of what our Coalition accomplished during the month of April. April Highlights: Reforming Patent Adjudication With PREVAIL The Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act was introduced by Senators Chris Coons (D-DE), Thom Tillis (R-NC), Dick Durbin (D-IL), and Mazie Hirono (D-HI)

Strong, consistent IP protections throughout U.S. history enabled the creation of the innovative and useful technologies that we use regularly today. From communication to entertainment, every aspect of our lives has benefited greatly from IP, as shown by these historical examples from the month of April: 1973: On April 17, Ralph Baer received a patent

Patents provide crucial incentives for inventors and businesses to invest time and funds into cutting-edge and emerging technologies. However, a series of Supreme Court decisions issued during the 2010s muddled the state of patent eligibility for many such technologies, such as medical diagnostics and artificial intelligence. The Patent Eligibility Restoration Act (PERA) would restore pre-2010

C4IP is recognizing Margaret Knight, one of the most prolific female inventors of the 19th century. She is best known for her invention of a machine for producing paper bags. Knight was born in York, Maine, in 1838, and worked in textile mills from a very early age following the death of her father. She created her first invention at

C4IP accomplished a lot during the month of March! Here’s a roundup of what our Coalition has been up to over the past month. March Highlights: Promoting Patent Eligibility Reform The Patent Eligibility Restoration Act (PERA), reintroduced by Senators Thom Tillis and Chris Coons in June, remains under consideration by the 118th Congress. This important bill would resolve the

Strong, consistent IP protections throughout U.S. history enabled the creation of the innovative and useful technologies that we use regularly today. From clothing to transportation, every aspect of our lives has benefited greatly from IP, as shown by these historical examples from the month of March: 1917: On March 20, Gideon Sundback received a patent for a “separable fastener” — known

This chaotic area of law harms American innovation and competitiveness Without Congressional consideration or endorsement, the Supreme Court has fundamentally altered the U.S. patent system by deciding that certain categories of innovation should not receive patents by widening the “judicial exceptions” to what is eligible to be patented under 35 U.S.C. § 101. Starting in

C4IP Co-Chairs and former USPTO Directors David Kappos and Andrei Iancu just published a new opinion piece in The Hill, which draws from C4IP’s newly released Congressional Innovation Scorecard to explain how the U.S. can fix the growing disparity between its R&D spending and China’s. The scorecard found that a supermajority of Congress — nearly

America’s strong intellectual property system played a pivotal role in the rapid global response to the COVID-19 pandemic. Patents provided crucial incentives for the development of life-saving vaccines, therapies, and diagnostic tests, all of which were distributed globally. However, despite these successes, there are ongoing efforts by certain global leaders to pursue an international agreement at the World Health Organization (WHO) that would erode